What the business is, and whether it's a good one at a fair price.
A Healthcare Equipment & Supplies company listed on NSE and BSE, reporting revenue of ₹441 Cr over the trailing twelve months.
Measured from the filed financials, judged against its Medical Equipment & Supplies peers · as of FY26 — not investment advice
How has the market priced it — with filings on the timeline?
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
How does it stack up on valuation, returns and growth?
Loading peers…
Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.
Loading financials…
Who owns it — and is the promoter stake clean?
Loading shareholding…
Sign up to see the full company file
Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.
Answered from TARSONS PRODUCTS LIMITED's filed financials and exchange disclosures
TARSONS PRODUCTS LIMITED is a Healthcare Equipment & Supplies company listed on NSE and BSE, trading under the symbol TARSONS.
Yes. Over the trailing twelve months TARSONS PRODUCTS LIMITED reported a net profit of ₹11 Cr on revenue of ₹441 Cr.
Not in the latest reported year — TARSONS PRODUCTS LIMITED's dividend payout for FY26 was nil.
No. Debt stands at 0.60× equity, and it carries net debt of ₹359 Cr. That is lower than 0% of its 11 Medical Equipment & Supplies peers.
On trailing P/E, TARSONS PRODUCTS LIMITED ranks 16 of 17 in Medical Equipment & Supplies — cheaper than 6% of them, against an industry median of 20.0×. This is a position, not a valuation judgement.
On a typical session TARSONS PRODUCTS LIMITED moves 1.26% — that is the median absolute close-to-close move across its last 268 trading days. Announcement days are routinely larger.
Every NSE and BSE filing by TARSONS PRODUCTS LIMITED appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.
Figures are as last reported and may lag the latest filing. Not investment advice.
